Anal Cancer Market is estimated to be valued at US$ 810.4 million in 2021 and is expected to exhibit a CAGR of 6.3% between 2021 and 2028 | Advaxis, Inc., ORYX GmbH and Co. KG, Eli Lilly and Company

Market Overview:

Anal cancer is an abnormal growth of cells in or around the anus or anal canal which is the short passage through which bowel movements pass. Treatment of recurrent anal cancer may include radiation therapy and chemotherapy.

Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4701

Competitive Landscape:

Major players operating in the global anal cancer market include, Amgen Inc., Atara Biotherapeutics Inc., Advaxis, Inc., Bristol-Myers Squibb Company, BioMimetix JV, LLC, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Global BioPharma Inc., GlaxoSmithKline plc, ISA Pharmaceuticals, Johnson & Johnson Private Limited, Merck KGaA, Novartis AG, ORYX GmbH and Co. KG, Ono Pharmaceutical Co., Ltd., Onconova Therapeutics, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Sanofi, Spectrum Pharmaceuticals Inc., and Takeda Pharmaceutical Company Limited.

Key Market Drivers:

Increasing prevalence of anal cancer is expected to propel growth of the global anal cancer market over the forecast period. For instance, according to the study, published in November 2019 in the Journal of the National Cancer Institute, from 2001 to 2015, the overall incidence of anal cancer increased by 2.7% per year and mortality jumped by 3.1% each year, in the U.S.

Moreover, increasing funding for R&D in anal cancer is also expected to propel growth of the global anal cancer market over the forecast period. For instance, in August 2021, The Icahn School of Medicine at Mount Sinai received a US$ 4 million grant from the National Cancer Institute for R&D in anal cancer screening in high-risk women diagnosed with HPV infection.

𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!!!!!!!

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/4701

Covid-19 Impact Analysis

In the U.S., from 3 January 2020 to 5:51pm CET, 16 December 2021, there have been 49,833,416 confirmed cases of COVID-19 with 792,371 deaths, reported to WHO. As of 9 December 2021, a total of 465,812,616 vaccine doses have been administered.

Key Takeaways

Major players operating in the global anal cancer market are focused on R&D to expand their product portfolio. For instance, in December 2021, SQZ Biotechnologies Company reported that its investigational therapy induced radiographic, symptomatic and immune response as monotherapy in post-checkpoint HPV+ solid tumor patient.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4701

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Type
     • Market Snippet, By Cancer Type
     • Market Snippet, By Treatment Type
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Pipeline Analysis
   • PEST Analysis
   • Regulatory Scenario
   • Market Trends
   • Key Highlights
   • Reimbursement Scenario
   • Mergers & Acquisitions
4. Global Anal Cancer Market – Impact of Coronavirus (Covid-19) Pandemic
   • Economic Impact
   • Impact on Clinical Trials and Drug Development
   • Government Initiatives
5. Global Anal Cancer Market, By Drug Type, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Fluorouracil
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Cisplatin
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Carboplatin
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Others (Others include Mitomycin, Oxaliplatin, Docetaxel, Leucovorin, etc.)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
6. Global Anal Cancer Market, By Cancer Type, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Carcinoma In-situ
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Squamous Cell Carcinoma
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Melanoma
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Adenocarcinoma
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Basal Cell Carcinoma
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
7. Global Anal Cancer Market, By Treatment Type, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Chemotherapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Surgery
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Radiation Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Immunotherapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
8. Global Anal Cancer Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Hospitals & Clinics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Research & Academic Institutes
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Long-term Care Centers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
9. Global Anal Cancer Market, By Region, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Region, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, For Regions, 2018–2028
   • North America
     • Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, By Cancer Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, By Treatment Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
       • U.S.
       • Canada
   • Latin America
     • Brazil
     • Mexico
     • Argentina
     • Rest of Latin America
   • Europe
     • Germany
     • U.K.
     • France
     • Italy
     • Spain
     • Russia
     • Rest of Europe
   • Asia Pacific
     • China
     • India
     • Japan
     • Australia
     • South Korea
     • ASEAN
     • Rest of Asia Pacific
   • Middle East
     • GCC
     • Israel
     • Rest of Middle East
   • Africa
     • South Africa
     • Central Africa
     • North Africa